Zenas BioPharma, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $10,000 | $5,000 |
Gross Profit | -5,000 | -43,027 | 10,000 | 5,000 |
EBITDA | -51,488 | -55,151 | -33,755 | -55,590 |
EBIT | -51,499 | -55,163 | -33,778 | -55,623 |
Net Income | -51,499 | -52,223 | -33,573 | -52,604 |
Net Change In Cash | 0 | 0 | 10,000 | 5,000 |
Free Cash Flow | -41,125 | -41,743 | -37,069 | -38,628 |
Cash | 115,565 | 44,006 | 196,554 | 319,742 |
Basic Shares | 42,159 | 41,865 | 41,800 | 41,790 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $5,000 | $50,000 | $0 |
Gross Profit | -134,139 | 50,000 | -61,689 |
EBITDA | -163,751 | -27,034 | -75,121 |
EBIT | -163,888 | -27,147 | -75,199 |
Net Income | -156,988 | -37,124 | -119,282 |
Net Change In Cash | 5,000 | 50,000 | 0 |
Free Cash Flow | -119,805 | -30,546 | -67,850 |
Cash | 319,742 | 56,857 | 67,209 |
Basic Shares | 41,785 | 38,317 | 38,317 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.22 |
2025-06-30 | -$1.25 |
2025-03-31 | -$0.80 |
2024-12-31 | -$1.26 |
